Contact sensitivity to dinitro-fluorobenzene in the mouse is a form of delayed-type hypersensitivity. This reaction is closely regulated. Tolerance to contact sensitivity is mediated by at least 2 mechanisms, tolerance without demonstrable suppressor cells and tolerance with suppressor T cells. Suppressor T cells can inhibit either the afferent limb of sensitization or the efferent (elicitation) phase. These cells probably operate via soluble suppressor factors and require auxiliary cells. The duration of contact sensitivity itself is controlled by another mechanism, which is antibody. This antibody is directed against the T cells responsible for the delayed hypersensitivity state (Tm~), and down-regulate these cells. It is antigen-specific and has the properties of an antireceptor (anti-idiotypic) antibody. This paper will summarize om experience with the regulation of contact sensitivity in the mouse. We have studied this model extensively over the past few years. It seemed to be a simple and straightforward system at first, but fuxther experimental results have shown that it is indeed very complex. Even now we do not understand the complete regulatory system. So far, however, we have uncovered a variety of mechanisms for modulating the response. These include 2 kinds of suppressor cells, a suppressor auxiliary cell, an antireceptor antibody and a state of tolerance without demonstrable suppressor mechanisms.
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I. CONTACT SENSITIZATION TO DINITROFLUOROBENZENE (DNFB) IN THE MOUSE
Contact sensitization to DNFB is easily induced in most (perhaps all) strains of mice by simply painting a solution of DNFB on the abdomen [1] . This activates the afferent limb of the response. The existence of the sensitized state can be shown by challenging the animal with another dose of (dilute) DNFB, thereby activating the efferent limb. This is done by applying DNFB to the ears and measuring ear swelling 24 hr later with a micrometer.
This response has the fo llowing charaCteristics. Therefore, it appears to be as classic a case of delayed type hypersensitivity as that seen with TNCB (picryl chloride) in the guinea pig. It does differ, however, in at least one respect in that sensitivity wanes rapidly with time. In our hands, peak sensitivity occurs 5 days after sensitization and has almost disappeared by 13 days.
II. TOLERANCE TO CONTACT SENSITIVITY
A very large number of experiments have been done to induce tolerance to contact sensitivity prior to sensitization (reviewed in reference 3). Tolerance to DNFB in mice can be induced by an i.v. injection of DNBSOJ. This tolerance is specific and longlasting. An interesting feature is that tolerance takes time to develop after DNBSOJ injection. While only about 30% unresponsiveness is seen 1-2 days after DNBS0 3 injection, a week later the mice are virtually completely tolerant [ 4] . A series of experiments then showed that the ability of a group of DNP congeners to tolerize was proportional to th eir ability to bind protein. This indicated that tolerance, like contact sensitivity itself, was probably mediated by DNP-protein conj ugates [5, 6] . As DNP-mouse gamma-globulin (a potent B cell tolerogen) did not induce tolerance to contact sensitization, it appeared likely that the "real" tolerogen formed in vivo after DNBS03 administration was DNP-membrane. Indeed, DNP coupled to syngeneic (or allogeneic) cells in vitro was a more powerful tolerogen than DNBS0 3 or free DNFB. Furthermore, DNP-LC (DNP-lymphoid cells), unlike DNBS0 3 , induced maximum tolerance immediately [7] . Analysis of these various features have uncovered several mechanisms of immunoregulation of contact allergy.
III. TOLERANCE WITHOUT SUPPRESSORS
Tolerance mediated via suppressive mechanisms will be discussed in detail later on in this paper. Nevertheless, we and our colleagues believe that significant tolerance can occur without suppressive mechanisms, and that this nonsuppressor pathway may indeed be the mo t important one.
The evidence that tolerance can occur in the absence of suppressor mechanisms comes from the following observations:
1. Tolerance can be induced "in1mediately" with DNP-LC while suppressor cells require time to develop.
2. Such "instant" tolerance cannot be transferred adoptively (as suppressor cells can), and mice "instantly" tolerized cannot suppress sensitized immigrant cells, in a reverse adoptive transfer [7) .
3. Situations known to inhibit development of suppressor cell systems, e.g., splenectomy, or prior treatment with cyclophosphamide, do not abrogate this state of tolerance [8] .
We envisage this state of tolerance to be one in which the tolerogen (DNP-LC) directly encounters the T cell (ToH) responsible for contact sensitivity to DNFB and thereby inactivates it. We do not know if this occw-s via blockade of the 264 CLAMAN AND MILLER receptors of that Tm1 or via some type of clone deletion. To cover both possibilities we have used the rather vague term, "clone inhibition." It is possible that this state of clone inhibition involves a pathway which bypasses the usually immunogenic route of antigen presentation which is stimulatory for ToH -This immunogenic route probably involves macrophage interaction with the antigen. It is significant that tolerization of ToH requires the intravenous route for the DNP-LC tolerogen, while subcutaneous innoculation of the some material leads not to tolerance but to sensitization [9] . It is also significant that the genetic requirements for tolerization are very similar to those for sensitization. That is, in animals syngeneic at the K and D ends of the major histocompatibility locus (MHC) efficient tolerance is induced with DNP-cells which are compatible with the recipient at the I region. 1-region incompatible cells do not tolerize [10] . Furthermore, if one compares various DNPcell preparations, the degree of tolerogenicity varies directly with the content of !-region gene products on the haptenated cell populations (unpublished). As T cells best "see" antigens in the context of !-region determinants when activation is concerned, it is quite logical to believe that the same is true when one is considering tolerance by clone inhibition-provided the tolerogen evades the "immunogenic route."
A warning is necessary here. It is a good scientific rule-ofthumb to recognize that "absence of proof is not the same as proof of absence." Although we have results in which we find tolerance without suppressors, it is possible that they are there but undetecte~ or unTecognized. We are continuing our search.
IV. TOLERANCE WITH SUPPRESSORS
Asherson and his colleagues showed that suppressor cells of T cell origin (Ts) were important in tolerance to contact sensitivity [11] and we reported similar findings at these Brook Lodge meetings in 1974 [12] . Further analysis of these Ts has proven very interesting.
Ts are only demonstrable for about 10 days after tolerization, yet tolerance lasts for 1-2 mo [5] . This is one of the reasons that we believe that Ts play only an incomplete role in the maintenance of tolerance and that clone inhibition occurs before and persists after Ts are found.
Additional complexity arises when one considers the results of the injection of DNP-syngeneic vs. DNP-allogeneic cells. In the case of the BALB/c mouse which we use "instant" tolerance occurs after the injection of either DNP-BALB/c-LC or of DNP-CBA-LC. In each case, Ts are demonstrable a week later. There are significant differences between the Ts induced in these cases.
Ts-eff (Ts Suppressing the Efferent Limb)
These Ts are induced by injection ofDNP-LC into syngeneic mice. These Ts are defined by their ability to inhibit the efferent (elicitation) limb of the contact sensitivity response. Operationally, they are assayed by the fact that they depress the passive transfer of contact sensitivity when given together with ToH from sensitized donors into naive recipients (Lansteiner-Chase type passive transfer). These Ts-eff do not inhibit the afferent limb of contact sensitivity. Thus, when given alone to a naive recipient, they do not inhibit the ability of that animal to develop To1-1 when painted on the abdomen with DNFB. Rather, they inhibit the expression of the To1-1; thus, the animal appears suppressed [13] .
The genetic restrictions on the action of Ts-eff require comment. At first we found that Ts-eff induced in BALBI c mice by injection of DNP-BALB/c mice by injection of DNP-BALB/c-LC were genetically unrestricted. That is, they would inhibit the passive transfer of ToH from BALB/c or CBA or C57Bl/6 (or presumably any other strain of) mice [13] . This kind of data is compatible with the idea that Ts-eff "see" an MHC product of public specificity or perhaps see no MHC product at all, only DNP.
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FuTther analysis of the phenomenon showed that the Ts so raised in BALB/c mice were really a polyclonal collection of Ts, each specific for DNP in conjunction with a specific MHC haplotype. This finding was determined by asking what DNPcongeners were capable of inhibiting Ts-eff from suppressing T01-1· We have shown that DNP-lysine, and heavily haptenated DNP-protein conjugates were incapable of "blocking" Ts function. Thus, Ts-eff do not appear to "see" hapten alone. When we made soluble membrane preparations from DNP-LC and tested them for their ability to block Ts-eff, several very interesting results were found. In terms of suppression of syngeneic TDJ-1, the suppressive action of Ts-eff was only blocked by pretreatment with soluble syngeneic DNP-LC membrane preparations, and not by syngeneic TNP-LC membranes [14] .
Further experiments showed that inhibition of syngeneic suppression could be achieved by DNP-modified-membrane preparations that were only H-2D-region compatible with the Ts donors. Thus, Ts antigen receptors in this system specifically recognize DNP-modified H-2D-region determinants. In contrast, we found that pretreatment of syninduced Ts with syngeneic DNP-LC membranes did not inhibit the ability to suppress allogeneic ToH-However, pretreatment of Ts with DNPallogeneic membrane which were H-2D-end compatible to the allogeneic target ToH eliminated their ability to suppress the specific allogeneic T 0 1-1, leaving intact suppression of syngeneic or third party T 0 1-1. We propose that pertubation ofthe immune system by intravenous injection of syngeneic DNP-LC leads to the induction of a polyclonal wave of DNP-specific Ts activity. Some members of this set of Ts rcognize DNP-self MHC determinants with moderate affinity and are thus specifically inhibited after pretreatment with those DNP-self determinants. Other members of this set display receptors which cross-react with high affinity with DNP-allogeneic determinants and thus suppress allogeneic T01-1 cells. These allosuppressive clones can thus be specifically inhibited only by pretreatment with DNP-LC membranes, MHC-compatible with the target ToH [14] . These newer findings are more in accord with our previous findings that T suppressors in contact sensitivity rcognize DNP in conjunction with the H-2D region of the MHC [15] .
Recent evidence (manuscript in preparation) also points to the importance of epitope density of hapten on the DNP-LC used as tolerogen on the MHC restrictions of the Ts-eff which are generated. Our normal labelling concentration, as described above, leads to polyclonal Ts which are induced by and recognize DNP-modified H-2D-end determinants. Lowering the concentration of DNFB used to modify the lymphoid cells by a factor of 100, leads to a MHC-restricted population ofTs which are induced by and recognize DNP-modified H-2K and/or H-2D-end determinants.
Ts-eff Require Ts-aux
Recent experiments show that Ts-eff cannot inhibit ToH alone, but that another antigen-specific T cell is needed. This cell, called an auxiliary T suppressor (Ts-aux), arises in sensitized mice together with To1-1. Together, ToH and Ts-aux provide a suitable target for the suppressive potency of Ts-eff [16] . The mode of interaction of these three cells, and/or their products, is not known.
Ts-aff (Ts Suppressing the Afferent Limb)
These Ts are induced by injection of DNP-allogeneic cells, e.g., DNP-CBA-LC into BALB/c mice. These Ts are defined by their ability to inhibit the afferent (sensitization) ljmb of the contact sensitivity response. Operationally, they are assayed by the fact that they depress the ability of naive animals to develop contact sensitivity when sensitized with DNFB epicutaneously. These Ts-aff do not inhibit the efferent limb, i.e., they do not inhibit the ability of To1-1 from sensitized mice to passively transfer sensitivity to normal recipients. Furthermore, unlike Ts-eff, these Ts-aff are genetically restricted. That is, Ts-aff A schematic representation of the afferent and efferent limbs of the contact sensitivity response and 3 suppressive mechanisms-Ts-aff, Tseff, and anti-receptor antibody.
induced in BALB/c mice by injection of DNP-CBA LC can only inhibit the development of contact sensitivity in mice which share the H-2D haplotype of the tolerogen, in this case H-2Dk [17] . It should be noted that the Ts induced by DNBSOa are also Ts-aff [18] .
V . NEGATIVE IMMUNOREGULATION BY ANTI-RECEPTOR ANTIBODY
Again, as shown by Asherson and colleagues, contact sensitivity can be regulated by B cells [19] . We mentioned above that contact sensitivity to DNFB in mice wanes with time after reaching its apogee at 5 days after sensitization. It now appears that the waning of sensitization occurs via the mediation of a specific antibody which appea1·s in the serum about 9 days after epicutaneous painting. This serum can suppress the passive transfer of sensitivity to DNFB when cotrimsferred to naive recipients together with ToH from sensitized donors. The suppressive activity of the serum is antigen-specific but the serum has no anti-DNP properties. Rather, it is adsorbed by ToH from DNFB-sensitized mice [20] . For this reason, we believe it is a true antireceptor antibody induced by and directed against specific ToH-Thus, it is a perfect vehicle for specifically limiting the duration, and perhaps, the magnitude of the contact sensitivity response.
VL REGULATORY SOLUBLE FACTORS IN CONTACT SENSITIVITY
Soluble suppressor factors (SSF) have been isolated in this same model of contact sensitivity and tolerance to DNFB. Detailed discussion of these is beyond the scope of this paper, but we should mention that one of these factors is antigenspecific, and inhibits the efferent limb of the immune response [21] . This SSF has affinity for antigen and is a product of the MHC. It is unusual in that it requires ide ntity (between the producer and the target) at either the H-2K or H-2D end of the MHC [22] . The precise relation between this SSF and the Ts mentioned above is under study. It is apparent that the seemingly simple model of contact allergy to DNFB can be controlled at several points and by IMMUNOREGULATION OF CONTACT SENSITIVITY 265 several mechanisms. The detailed targets of control and the means by which controls are exerted are still being investigated.
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